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Abstract In this study, we introduced the bovine
immunoglobulin μ heavy-chain gene (the orphaned gene
on BTA11) into mouse germline cells. Bovine IgM was
highly expressed in selected transgenic lines, and it largely
inhibited rearrangements of the endogenous immunoglo-
bulin heavy chain (IgH) genes in these lines. The forced
expression of bovine IgM resulted in reduced numbers of
pro- and pre-B cells but increased the number of immature
B cells in the transgenic mice. Bovine IgM-expressing B
cells can migrate from the bone marrow to the spleen, but
most of the cells are arrested at the T1 transitional B cell
stage, leading to a signiﬁcantly lower number of T2
transitional and mature B cells in the spleen. Although the
serum concentrations of endogenous IgM and IgG in the
transgenic mice were signiﬁcantly decreased, the IgA
levels were slightly increased compared to the WT mice.
The bovine IgM level in the serum was only one-tenth to
one-ﬁfth of that of endogenous mouse IgM, suggesting that
most of the serum immunoglobulin were contributed by
endogenous IgH gene-expressing B cells. These transgenic
mice also exhibited a lower frequency of unique
complementarity determining region 3 (CDR3) sequences
in their VH repertoire and Vκ repertoire but exhibited an
increased frequency of unique CDR3 in their Vλ
repertoire. Compared to the WT mice, the transgenic
mice had a signiﬁcantly higher percentage of mouse IgM-
expressing B cells that expressed λ chains. Finally, we
showed that the transgenic mice were deﬁcient in a speciﬁc
antibody response to antigen stimulation.
Keywords bovine Ig μ heavy-chain, transgenic mice, B
cell development, allelic exclusion, immune response, Ig
repertoire
1 Introduction
B cells are one of the deﬁning features of the immune
systems of jawed vertebrates, and they are responsible for
the production of a highly diverse repertoire of immuno-
globulins that are essential in defending the host against the
invading pathogens that the animal confronts during its
lifetime [1,2]. In humans and mice, B cell development is
strictly regulated and is tightly associated with the
expression of surface immunoglobulins, or B cell receptors
(BCR) [3]. In early pro-B cells, the rearrangement of the
diversity gene segments (DH) and joining gene segments
(JH) of heavy chain takes place on both immunoglobulin
heavy chain (IgH) alleles [4] and is followed by the
addition of the variable gene segments of heavy chain
(VH) to the newly-formed DH-JH segment to generate a
complete exon that encodes the variable region of an IgH
in late pro-B cells. Successfully transcribed and translated
IgH proteins are tested for functionality by pairing with a
surrogate light chain (SLC), thereby creating a pre-BCR in
large pre-B cells. The interaction of Igα/Igβ with the pre-
BCR drives further B cell development and the initiation of
Ig light chain (IgL) rearrangement [5–8]. The successful
expression of an IgL and its assembly with the IgM heavy
chain creates a true BCR (IgM isotype), an essential
surface marker of immature B cells in the bone marrow.
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The immature B cells then migrate from the bone marrow
to the peripheral lymphoid organs, where they reach
maturity and begin co-expressing surface IgM and IgD.
During B cell development, a series of regulatory
mechanisms and checkpoints guarantees the proper
expression of the BCR, which in turn signals further B
cell differentiation. Although DH-JH rearrangement is
initiated on both IgH alleles in early pro-B cells [4],
successful assembly of VH with DH-JH usually occurs for
only one IgH allele, thus ensuring the mono-speciﬁcity of
the BCR in a given B cell, a phenomenon known as “allelic
exclusion” [9,10]. Although many models have been
proposed for allelic exclusion, it is now generally accepted
that feedback inhibition from the translation of the
successfully rearranged ﬁrst allele and the binding of its
protein product to the SLC functions to prevent further VH
to DH-JH rearrangement of the other allele [11]. A large
number of studies using transgenic mice have demon-
strated that expression of the membrane-bound forms of
IgH genes (including μ, δ and γ) is able to mediate allelic
exclusion. One prerequisite for the feedback model is that
the rearranged allele must be transcribed and, more
essentially, translated to produce heavy chain products
that bind to SLCs to form the pre-BCR. This requirement
was challenged by a recent study that used transgenic mice
to demonstrate that the accumulation of non-translatable
IgH mRNA in early pro-B cells was able to mediate allelic
exclusion [12]. These data argue that feedback inhibition
by pre-BCR may not be the only mechanism responsible
for IgH allelic exclusion [12].
The elucidation of IgH allelic exclusion has beneﬁted
from the generation of large numbers of transgenic mouse
lines [13–17] in which rearranged human or mouse IgH
genes were randomly introduced into the mouse genome,
typically at locations separate from the endogenous IgH
locus. These genetic modiﬁcations created two IgH loci on
different chromosomes. In addition to inhibition of
rearrangements at the endogenous IgH loci, the expression
of transgenic IgH genes has also been reported to cause
severe B cell deﬁciency [18,19]. However, the mechanisms
behind this phenomenon are unclear.
In the work reported here, we have chosen to explore
these effects using an IgH locus that is phylogenetically
distant from systems used thus far. Although IgM is the
sole antibody class expressed in all jawed vertebrates and
is structurally conserved [2], bovine IgM is relatively
distinct from IgM of mice and humans in sequence and
phylogeny [20] and hence its ability to exercise allelic
exclusion with the endogenous loci of the mouse is
potentially informative.
The generation of transgenic mouse lines carrying an
IgM locus from cattle also has the potential to explore
aspects of bovine immunology. In mammals, the co-
existence of two functional IgH loci has rarely been
observed, but cattle, and perhaps sheep, are notable
exceptions [21,22]. In cattle, it has long been recognized
that a μ gene is present on Bos taurus autosome (BTA) 11,
whereas the major bovine IgH locus (encoding IgM, IgG,
IgD, IgE and IgA) maps to BTA 21 [23]. Initially, the μ
gene on BTA 11 was thought to be a pseudogene [21].
However, recent studies have revealed that it can be
functionally expressed, albeit at very low levels [24]. We
recently sequenced a bacterial artiﬁcial chromosome
(BAC) clone (944D11) that contained the μ gene from
BTA 11 and demonstrated that the μ gene appeared to be
structurally intact and functional. However, there is a
pseudo-δ gene downstream of the μ gene, and additional
IgH constant region (IGHC) genes could not be located.
Nonetheless, structurally intact DH and JH gene segments
were found upstream of the μ gene. Our study therefore
addresses the ability of this locus to undergo rearrangement
and expression and thereby contribute in a signiﬁcant way
to the functional repertoire of the host.
2 Materials and methods
2.1 Ethics statement
All animal work was conducted according to the guidelines
for the care and use of experimental animals established by
the Ministry of Science and Technology of the People’s
Republic of China (Approval number: 2006-398).
2.2 Bovine BAC clone and the construction of transgenic
BAC vectors
The bovine BAC clone 944D11 was previously isolated
from a genomic BAC library [25,26]. On the basis of the
BAC clone, we designed two transgenic BAC vectors
(mVH-bBAC and mPL-bVH-bBAC) with genetic mod-
iﬁcations.
To make the mVH-bBAC construct, the mouse VH
segment was ampliﬁed from the tail DNA of C57BL/6
mice by PCR with primers J558.67.166-Promoter1 and
J558.67.166-VHas2 (Appendix A-Table S1). The product
comprised the VH-J558 lymphocyte-speciﬁc VH promo-
ter, the complete VH segment and the recombination signal
sequence (RSS) at the downstream terminus of the
segment. Homologous arms for recombination were then
added to the fragment by PCR with another set of primers:
6801-P1 and 7861-V2 (Appendix A-Table S1). As a result,
the complete upper arm was comprised of a Nhe I site, an
80-bp BACDNA sequence and an EcoR I site, whereas the
lower arm was comprised of an 80-bp BACDNA sequence
and a Nhe I site. An FRT-zeocin cassette was then
introduced into the upper homologous arm in the EcoR I
site. Next, the BAC DNA was modiﬁed with the
recombined DNA fragment using the classical phage λ
red homologous recombination system. The Zeocin
cassette between the two FRT sites was excised using the
FLP recombination system. Finally, the site-speciﬁc
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integration of the mouse VH segment into the BAC was
conﬁrmed by PCR with two sets of primers: F-6739 with
R-7110 and F-8594 with R-9175 (Appendix A-Table S1).
To make the mPL-bVH-bBAC construct, a mouse
genomic segment (termed mPL) including the promoter
and a leader peptide-encoding sequence was produced by
PCR with primers J558.67.166-Promoter1 and mouse
VJ558.67.166-Leaderas (Appendix A-Table S1). A rear-
ranged bovine VDJ fragment was ampliﬁed from Holstein
cattle spleen cDNA by PCR with primers speciﬁc for the
bovine VH segments and JH6 segment, respectively. The
bovine VDJ fragment was fused to the mouse PL segment
via fusion PCR and subsequently cloned into the PMD
19-T vector (Takara, Dalian) and sequenced. Homologous
arms for recombination were then added to the fragment by
PCR with another set of primers: 54064-P1 and 56092-
JH6as (Appendix A-Table S1). The resulting fragment was
used to replace the bovine JH locus in the BAC clone with
a strategy similar to that used to generate the mVH-bBAC
construct. The site-speciﬁc integration of the bovine VDJ
fragment into the BAC was also conﬁrmed by PCR with
two sets of primers: F-53926 with R-54263 and F-55797
with R-56214 (Appendix A-Table S1). All of the PCR
products were cloned into PMD 19-T vectors (Takara) and
sequenced.
2.3 Generation and identiﬁcation of transgenic mice
DNA representing two modiﬁed BAC constructs was
prepared with a NucleoBond Xtra Maxi Kit following the
manufacturer’s protocol (Macherey-Nagel, Düren),
digested with Not I and separated on a 1% agarose gel
using the CHEF-DR III system (Bio-Rad). The BAC insert
DNA was subsequently puriﬁed by electroelution with
dialysis and dissolved in injection buffer. The puriﬁed
BAC DNA was microinjected into the pronuclei of
fertilized Kunming-White eggs following standard proto-
cols.
Genomic DNA was isolated from tail biopsies of F0
generation mice by phenol/chloroform extraction, and the
integrity of the two transgenes was conﬁrmed by PCR with
several pairs of primers.
To perform Southern blotting, 20 µg of genomic DNA
was digested with Sac I (Promega, USA) and hybridized to
the bovine constant region exon 1 to 2 of heavy chain
(CH1-2) with a DIG-labeled probe. The probe was
produced by PCR with probe-F and probe-R primers.
Hybridization and detection were performed using a DIG
High Prime DNA Labeling and Detection Starter Kit II
following the manufacturer’s instructions (Roche). Trans-
genic mouse lines were propagated by mating positive F0
mice with WT mice.
2.4 Genome walking
The insertion site of bovine BAC DNA in mice was
conﬁrmed by genome walking. According to the manu-
facturer’s instructions of the genome walking kit (Clon-
tech, CA, USA), ampliﬁcations from 3′- ends of the BAC
DNAwere achieved by nest-PCR with two sets of primers:
F-126849 with AP1 and F-126886 with AP2 (Appendix A-
Table S1). All ampliﬁcations were using LA Taq DNA
polymerase (Takara, Dalian, China). All of the PCR
products were cloned into PMD 19-T vectors (Takara) and
sequenced.
2.5 RNA isolation and RT-PCR analysis of transgene
expression
Total RNA samples were isolated from various tissues of
8- to 16-week-old positive mice using TRIzol reagent
(Kangwei Biotech, Chongqing), and reverse transcription
was performed using M-MLV Reverse Transcriptase
following the manufacturer’s instructions (Promega,
USA). RT-PCR was used to examine the tissue-speciﬁc
expression of bIgM using the bovine JH6-forward and
bovine Cμ1-reverse primers speciﬁc to the bovine μCH1
exon. Mouse β-actin was ampliﬁed as an internal control
with primers F and R. The mVH transgene expression was
examined by PCR with mouse-FVH and bovine-RCH1
primers, whereas bovine IgM expression was detected by
PCR with bFCH2 and bRCH2 primers (Appendix A-Table
S1) speciﬁc to the bovine μCH2 exon. Furthermore, the
VDJ sequence of the bovine IgM transcripts was ampliﬁed
by 5′ RACE with bCμ-GSP2 and bCμ-GSP3 primers
(Appendix A-Table S1) speciﬁc to the bovine μCH1 exon,
following the manufacturer’s protocol (Invitrogen,
USA).
2.6 Detection of trans-spliced RNA
IgH transcripts derived from the trans-splicing of the
bovine VH and endogenous mouse constant genes were
detected by RT-PCR. Chimeric IgA transcripts were
detected with the primers bVH3 and mCα-2 (Appendix
A-Table S1). Similarly, chimeric IgG transcripts were
detected with the primers bVH3 and mCγ (Appendix A-
Table S1). The sequence of mCγ was conserved among the
mouse Cγ1, Cγ2b and Cγ3 genes. Chimeric IgD transcripts
were examined via nested PCR with the primers bVH1 and
mCδ-2, as well as bVH3 and mCδ-3 (Appendix A-
Table S1).
2.7 Western blotting
The serum samples collected from 8- to 16-week-old
transgenic mice were separated by SDS-PAGE, electro-
phoretically transferred onto Immobilon-P membranes
(Millipore, Billerica, MA) and treated following a standard
protocol. Immunodetection was conducted with HRP-
conjugated antibodies, including goat anti-mouse IgM (μ
chain) (Rockland Immunochemicals, Gilbertsville, PA),
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goat anti-bovine IgM (μ chain) (KPL, Gaithersburg,
Maryland), rabbit anti-mouse kappa chain (Acris GmbH,
Herford) and rabbit anti-mouse lamda chain (Acris GmbH,
Herford). Enhanced chemiluminescence and autoradiogra-
phy were performed using ECL western blotting reagents
(Amersham Biosciences, UK). Serum samples from age-
matched WT mice served as negative controls.
2.8 Flow cytometry analysis
Single-cell suspensions were prepared by passing tissue
samples through 200-μm nylon mesh and resuspending the
ﬁltered cells in PBS. Erythrocytes were lysed in 1  RBC
lysis buffer (eBioscience, San Diego, CA). For three-color
ﬂuorescence surface staining, approximately 106 cells per
sample were incubated with varying antibody combina-
tions according to a standard protocol. The labeled
antibodies included FITC anti-bovine IgM (AbD Serotec,
UK), FITC anti-mouse IgM (eBioscience), PE anti-mouse
IgM (Biolegend, San Diego, CA), PE anti-mouse CD43
(eBioscience), PE anti-mouse IgD (eBioscience), PE anti-
mouse kappa chain (Acris Antibodies GmbH), PE anti-
mouse lamda chain (Biolegend), PerCP/cy5.5 anti-mouse
kappa chain (BD Biosciences, San Jose, CA), PE anti-
mouse CD138 (BD Biosciences), PE anti-mouse CD21/
CD35 (eBioscience) and PE/cy5.5 anti-mouse B220
(CD45R) (eBioscience).
The cells were collected from the transgenic mice at 8 to
16 weeks of age in parallel with age-matched controls.
Twenty thousand cells were collected for each sample. All
of the data were acquired on a MoFlo ﬂow cytometer and
analyzed using Summit software (Beckman Coulter,
Fullerton, CA).
2.9 OVA immunization and ELISA
The OVA antigen (ovalbumin, Sigma, USA) was resus-
pended in Montanide ISA 70 adjuvant (1:1). Then, 6- to 8-
week-old mice from two transgenic lines and the WT
group were intramuscularly immunized with 1 μg$μL–1
OVA twice. Each group included four mice. All of the mice
received a primary injection on day 0 and a secondary
injection on day 14. Serum samples were collected on day
21 and examined using mouse anti-OVA IgG and anti-
OVA IgM Elisa Kit respectively following the manufac-
turer’s instructions (ADI, San Antonio,Texas). The serum
anti-OVA IgG concentration was determined from dilu-
tions of 1:150000 (transgenic mice) or 1:30000 (WT
mice),while the serum anti-OVA IgM concentration was
determined from dilutions of 1:100 (transgenic mice) or
1:10 (WT mice). The serum levels of pre- and post-
immunization mice in different groups were measured
using ELISA kits for mouse IgM, IgG and IgA and bovine
IgM following the manufacturer’s instructions (ADI, San
Antonio, Texas).
2.10 Ampliﬁcation and repertoire analysis of rearranged
endogenous mouse VH and variable gene of light chain (VL)
genes from the spleen
For VH gene ampliﬁcation, PCR was performed using a
pool of 16 equivalent VH family forward primers and the
reverse primer Cμ. For VL ampliﬁcations, splenocytes that
were positive for transgenic bovine IgM and mouse IgM
were sorted by ﬂow cytometry (Beckman Coulter), and
total RNA was extracted using an RNeasy Mini Kit
(Qiagen, Armenia) and an RNase-Free DNase Kit (Qia-
gen). Reverse transcription was performed with
SuperScript III Reverse Transcriptase following the
manufacturer’s instructions (Promega). PCR ampliﬁcation
was performed using Phusion DNA polymerase (NEB,
Ipswich, MA). The oligonucleotide primers used for
reverse transcription were RTCκ and RTCλ. The forward
primers used for Vκ and Vλ detection were pools of 19 Vκ
and 8 Vλ primers, and the reverse primers were Cκ and Cλ,
respectively (Appendix A-Table S1).
2.11 Statistical analysis
The statistical analyses in this study were performed using
two-tailed Student t-tests and Chi-square tests.
3 Results
3.1 Construction of transgenic BAC vectors and the
generation of transgenic mice
The bovine BAC clone 944D11 was previously isolated
from a genomic BAC library [25] and sequenced using a
shotgun-based approach. The BAC was shown to contain
DH and JH segments, as well as an intact μ and a pseudo-δ
gene. Using the backbone of this BAC clone, we designed
two transgenic BAC vectors (mVH-bBAC and mPL-bVH-
bBAC) with genetic modiﬁcations (Fig. 1). In mVH-
bBAC, a mouse VH segment consisting of a VH promoter,
a VH coding sequence and an intact recombination signal
sequence was inserted upstream of the bovine DH locus.
Therefore, rearrangement and expression of this construct
has the potential to generate a chimeric mouse-bovine IgH.
In the second construct, mPL-bVH-bBAC, a fused
genomic fragment consisting of a mouse VH promoter
and a rearranged bovine VDJ exon was used to replace the
JH locus in the original BAC, thereby creating the potential
for expression of a bovine IgH. The construction details are
shown in Appendix B-Fig. S1.
The inserts for the two constructs (mVH-bBAC and
mPL-bVH-bBAC) were isolated from the BAC vector by
Not I digestion and used to create transgenic mice by
microinjection. Mice of the F0 generation were examined
for the presence of transgenes by both PCR and Southern
blotting (Fig. 2). Five mice (Founders 1, 2, 8, 9 and 10) out
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of 23 tested were mVH-bBAC-positive (Fig. 2a), whereas
8 (Founders 7, 14, 15, 19, 22, 24, 27 and 31) out of an
additional 31 mice had the mPL-bVH-bBAC transgene
(Fig. 2b).
The aforementioned transgenic founders were mated
with WT mice, and the expression of bovine IgM in the
resulting transgenic offspring was examined by RT-PCR
and ﬂow cytometry. RT-PCR detected bovine IgM heavy-
chain transcripts in all transgenic lines and therefore the
bovine DH and JH segments present on BTA 11 are
capable of undergoing rearrangement. However, very little
surface bovine IgM could be detected on the B cells in any
mVH-bBAC transgenic mouse. B cell development was
largely unaffected by the transgene in mVH-bBAC mice
compared to the WT mice. In two lines of mPL-bVH-
bBAC transgenic mice (Lines 15 and 22), the bovine IgM
was highly expressed on most splenic B cells, and B cell
development was remarkably disturbed in these mice.
These two transgenic lines were thus chosen for further
investigation in subsequent experiments. At the same time,
the mPL-bVH-bBAC transgene was located on mouse
chromosome 14 using genome walking.
Fig. 1 Schematic map of the two modiﬁed transgenic BAC vectors. (a) mVH-bBAC vector; (b) mPL-bVH-bBAC vector. Gene elements
are indicated by different boxes. P, L and RSS denote the promoter, leader peptide and recombination signal sequence, respectively.
Squares with differently hatched ﬁlls, abbreviated as H-A, indicate homologous arms. The FRT elements are depicted as triangles. Heavy
chain variable (VH), diversity (DH), joining (JH) and constant (CH) region coding segments are shown as black squares. The proportional
scales for the two transgenes are also indicated.
Fig. 2 Southern blot analysis of the transgenic mice. (a) Analysis of the founders of the mVH-bBAC vector transgenic lines; (b) analysis
of the founders of the mPL-bVH-bBAC vector transgenic lines. The hybridized μ and pseudo-δ genes are 3.5 and 5.9 kb in length,
respectively; The genomic DNA of a WT mouse is used as a negative control (NC); Line 7 was shown to be transgene-positive by PCR
and another Southern blotting experiment.
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3.2 B cell development is altered by high bovine IgM
expression levels
To examine B cell development in the transgenic mice, a
series of antibodies against B cell surface markers was
utilized to characterize the B cell populations in the bone
marrow, spleen and peripheral blood leukocytes (PBL). In
transgenic lines with low levels of bovine IgM expression,
the expression of endogenous mouse IgM was nearly
normal. Correspondingly, the percentages of different B
cell subsets in these mice were nearly the same as those in
WT mice (data not shown). However, the expression of
endogenous mouse IgM was severely diminished in the
two mPL-bVH-bBAC transgenic lines (Lines 15 and 22)
that highly expressed bovine IgM (Fig. 3). In Lines 15 and
22, the expression of the bovine VH (with VDJ already
rearranged in the germline) was driven by a mouse B cell-
speciﬁc VH promoter. These data suggest that allelic
exclusion was largely enforced by the expression of
transgenic bovine IgM in Lines 15 and 22 despite the
sequence differences between bovine and murine IgM.
Anti-CD43 and anti-mouse IgM antibody staining of bone
marrow B cells from the transgenic mice indicated that the
proportion of immature B cells was markedly reduced
compared to that in WT mice (2.9%0.7% vs. 24.3%
3.7%, P< 0.001). The proportions of pro-and pre-B cells
were also signiﬁcantly different in the two groups
(P< 0.01 and P< 0. 001, respectively) (Fig. 3a and Fig.
3d). Pro- and pre-B cells were detected at remarkably
decreased levels when anti-bovine IgM antibody was used
to identify these subsets. However, the proportion of
immature B cells (expressing bovine IgM) was signiﬁ-
cantly increased by roughly twofold (56.7%6.9% vs.
24.3%3.7%, P< 0.01) (Fig. 3a and Fig. 3d). Therefore,
the forced expression of bovine IgM appeared to facilitate
the development of B cells from pro- and pre-B cells to
immature B cells in the bone marrow.
Splenic B cells can be categorized as transitional (T1 and
T2) or mature B cells based on their surface expression of
IgM and IgD [27,28]. In WT mice, mature B cells
(IgD+IgM–) account for a large portion of the B cells in the
spleen, whereas T1 (IgD–IgM+) and T2 (IgD+IgM+) B
cells together account for approximately half of the mature
B cells (Fig. 3b). Using mouse IgD and IgM as surface
markers, mature B cells were found to be almost
completely depleted in transgenic mice (2.1%1.1% vs.
60.3%5.4%, P< 0.001). In addition, markedly fewer T2
B cells were detected in the spleens of transgenic mice
(4.0%1.0% vs. 8.6%3.2%, P< 0.01), though the
proportion of T1 B cells expressing mouse IgM was not
signiﬁcantly different from that in WT mice (14.0%2.4%
vs. 14.0%3.2%, P>0.05) (Fig. 3b and Fig. 3e). Similarly,
when mouse IgD and bovine IgM were used as surface
markers, very few mature B cells (2.6%1.2% vs.
60.0%2.4%, P< 0.001) and fewer T2 B cells (5.4%
2.3% vs. 8.6%3.2%, P< 0.05) were detected. A large
portion of B cells (70.0%4.7%) expressed bovine IgM
and was arrested at the T1 stage (Fig. 3b and Fig. 3e). The
near depletion of mature B cells was also conﬁrmed using
CD21 as a surface marker [27], though the T2 population
accounted for a higher percentage in this analysis (Fig. 4a
and Fig. 4b) than in the analysis using bovine IgM and
mouse IgD. Nonetheless, the analysis using CD21 also
demonstrated that most bovine IgM-expressing B cells
were blocked at the T1 stage. Further, our analysis
demonstrated that a small portion of splenic (10.0%
2.9%) and blood (6.6%0.9%) B cells in transgenic mice
expressed both bovine IgM and murine IgM on their
surfaces (Fig. 4c).
3.3 Detection of endogenous immunoglobulins and bovine
IgM in the serum of transgenic mice
The concentrations of total endogenous IgM, IgG and IgA
and bovine IgM in both transgenic and WT mice were
examined by ELISA. In transgenic Line 15, the concentra-
tions of endogenous IgM and IgG were reduced to
approximately one-third and one-half of those in WT
mice, respectively (P< 0.05) (Fig. 5a), whereas the IgA
level appeared to be slightly increased (P>0.05) (Fig. 5a).
Although the bovine IgM-expressing B cells represented a
large proportion of the B cells in the bone marrow, spleen
and PBL, the concentration of bovine IgM in the serum
was only approximately one-tenth of that of the endogen-
ous mouse IgM concentration (Fig. 5b), likely because
most of the bovine IgM-positive B cells were arrested at
the T1 stage and could not develop into mature B cells or
plasma cells.
Although the percentages of mature B cells in the
transgenic mice were signiﬁcantly reduced to approxi-
mately 1/20 to 1/40 of those of the WT mice, the levels of
the different mouse Ig classes in the serum were not
affected to a proportional extent. We analyzed the
percentages of plasma cells in different tissues of
transgenic and WT mice and found that the values in the
transgenic mice were approximately 60%–75% of those in
the WT mice (in the bone marrow: 0.40%0.03% vs.
0.63%0.06%, P< 0.001. in the spleen: 1.12%0.19%
vs. 1.49%0.23%, P< 0.05; and in the PBL: 0.37%
0.03% vs. 0.44%0.05%, P< 0.05). The number of total
B cells in the bone marrow, spleen and PBL in Lines 15
and 22 was reduced to approximately 40%–75% of that of
WT mice (in the bone marrow: 4.65%0.48% vs. 7.72%
0.78%, P< 0.001; in the spleen: 29.0%6.3% vs. 40.0%
4.5%, P< 0.05; and in the PBL: 4.6%1.1% vs. 10.6%
1.4%, P< 0.01) (Fig. 6).
3.4 Bovine IgM high-expressing transgenic mice are
deﬁcient in the speciﬁc IgG antibody response
Two groups of mice (Line 15 and WT, ﬁve mice for each
group), aged 6 to 8 weeks, were intramuscularly
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Fig. 3 Flow cytometry analysis of B cell populations in the bone marrow, spleen and PBL of transgenic (Thigh) and WT mice.
(a) Measurements of three cell subsets in bone marrow. The percentages of pro-B (B220+CD43+IgM–), pre-B (B220+CD43–IgM–) and
immature B (B220+CD43–IgM+) cells are indicated in each gate; (b) measurements of the three cell subsets were taken in the spleen;
(c) measurements of the three cell subsets were taken the PBL. The percentages of T1 (B220+IgD–IgM+), T2 (B220+IgD+IgM+) and
mature (B220+IgD+IgM–) B cells are indicated in each gate. Each set contains data from transgenic (Thigh) and WTanimals, respectively.
A total of 20000 events were collected for each sample. Plots are representative of measurements in at least ﬁve individual mice;
(d) statistical analysis of bone marrow B cell subset percentages in subﬁgure a with black, gray and white bars representing transgenic
mice with anti-bovine IgM antibody, transgenic mice with anti-mouse IgM antibody and WT mice with anti-mouse IgM antibody,
respectively; (e) statistical analysis of B cell subset percentages in the spleen based on subﬁgure b. Signiﬁcance values were determined by
a two-tailed Student t test (*: P< 0.05, **: P< 0.01, ***: P< 0.001).
immunized with OVA. All of the mice were given a
primary injection on day 0 and a second injection on day
14. Serum samples were collected before immunization
and 1 week after the second immunization. The samples
were used to detect the concentrations of OVA antigen-
speciﬁc IgG, OVA antigen-speciﬁc IgM, total IgM, IgG,
IgA and bovine IgM. On average, control mice exhibited
2-, 3.7- and 1.2-fold increases in the concentrations of total
IgM, IgG and IgA, respectively (Fig. 5a). The transgenic
mice in Line 15 demonstrated 1.3-, 2.2- and 1.27-fold
increases in the total concentrations of the three Ig classes
(Fig. 5a), though no increase in the concentration of bovine
IgM was detected (Fig. 5b). On average, the OVA-speciﬁc
IgM concentration was about 4.3-fold increases between
the immunized Line 15 transgenic mice to the control
mice. The OVA-speciﬁc IgG concentration was about
3.27108 U$mL–1 in the immunized control mice but only
about 4.76107 U$mL–1 in the Line 15 transgenic mice, a
reduction of approximately 6.87-fold (P< 0.05) (Fig. 5b).
These data suggest that the transgenic mice were deﬁcient
in the ability to mount the speciﬁc IgG response.
3.5 Expression of endogenous IgL in transgenic mice
Western blotting using mouse λ or κ light-chain-speciﬁc
antibodies revealed an increase in the λ/κ ratio in the serum
of transgenic mice compared to WT mice (Fig. 7a).
However, surface staining of the two light chains on
splenic B cells revealed similar or even greater κ/λ ratios in
the transgenic mice compared to those in the WT mice
(Fig. 7b and Fig. 7d). To investigate this apparent
discrepancy, the κ/λ ratios in endogenous mouse IgM-
and bovine IgM-expressing B cells were further examined
and compared to the ratio in IgM-expressing B cells of WT
mice. Although bovine IgM-expressing B cells exhibited a
similar κ/λ ratio (~30) to that observed in the mouse IgM-
expressing B cells of the WT mice, this ratio was
signiﬁcantly reduced in the mouse IgM-expressing B
cells of the transgenic mice (ranging from one-ninth to
one-half of the WT mice values) (P< 0.001) (Fig. 7c and
Fig. 7e). This reduction indicates that a signiﬁcantly
greater percentage of mouse IgM-expressing B cells
tended to use λ chains in the transgenic mice. Although
Fig. 4 Flow cytometry analysis of splenic lymphocytes from transgenic (Thigh) and WT mice. (a) Cells were stained for B220, IgM
(bIgM/mIgM) and CD21, and the proportion of the cell population corresponding to T1 (B220+CD21–IgM+), T2 (B220+CD21+IgM+)
and mature (B220+CD21+IgM–) B cells is indicated for each gate. The data are representative of four independent samples; (b) statistical
analysis of T1, T2 and mature B cells in transgenic and WT mice by two-tailed Student t tests (**: P< 0.01, ***: P< 0.001); (c) FACS
analysis of cells stained for B220, bIgM and mIgM. The numbers in each plot correspond to the cell percentages contained within each
gate. The data presented are representative of measurements in at least ﬁve individual mice.
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mouse IgM-expressing B cells were far outnumbered by
bovine IgM-expressing B cells in the spleen, the former
contributed more immunoglobulins in the serum of
transgenic mice, as mentioned above. This may explain
why the transgenic mice exhibited increased λ/κ ratios in
the serum compared to the WT mice.
3.6 The transgenic bovine VDJ exon is rarely if ever
mutated and could be trans-spliced to endogenous IGHC
genes
The bovine VDJ sequences expressed in the spleen were
ampliﬁed and cloned. A total of 47 clones (with inserts of
approximately 300 bp) were sequenced. Of these, eight
clones contained a total of ten point mutations, whereas 39
clones contained no mutations. The ten point mutations
caused seven different amino acid changes and were not
concentrated in the complementarity determining region
(CDR) but were evenly distributed within the VDJ exon. It
is difﬁcult to judge whether these observed mutations
resulted from somatic hypermutation in B cells or PCR
errors. Nevertheless, these mutations were mostly A to G
transitions and therefore clearly distinct from naturally
occurring mutations in bovine IgH genes [29,30]. No
Fig. 5 ELISA measurement of serum Ig concentrations. Serum Ig concentrations were measured both before and after OVA
immunization. (a) Concentrations of total endogenous IgA, IgG and IgM; (b) concentrations of bovine IgM, anti-OVA IgM and anti-OVA
IgG in the three groups. Each point represents the antibody concentration in the serum of an individual mouse. The units of Ig content are
indicated in each ﬁgure. The horizontal bars represent the mean, and the error bars represent the standard error of the mean expression
level. P values were analyzed using two-tailed Student t tests (*: P< 0.05, **: P< 0.01).
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mutations were located in the RGYW hotspots.
Previous studies have reported that the VDJ exon of
transgenic IgH genes can be trans-spliced to endogenous
IGHC genes [31,32]. To assess whether this was possible
in the transgenic animals generated here, bovine VDJ-
speciﬁc primers and primers speciﬁc to each of the
Fig. 6 Flow cytometric analysis of plasma cells and B cells in the bone marrow, spleen and PBL. (a) Gates indicate the plasma cell
subset (CD138+B220–) and the B cell subset (CD138–B220+). The proportion of cells within each gate is indicated in the ﬁgure. The plots
are representative of measurements in at least ﬁve individual mice; (b) statistical analysis of percentages of B cells and plasma cells in
various tissues based on the data from subﬁgure a. P values were analyzed using two-tailed Student t tests (*: P< 0.05, **: P< 0.01, ***:
P< 0.001).
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Fig. 7 Expression analysis of light chains in transgenic (Thigh) and WTmice. (a) Analysis of mouse κ or λ light chains in sera by western
blotting. Four mice from each group were evaluated; (b) FACS analysis of mouse κ and λ light chains on splenic B cells; (c) FACS proﬁles
of splenic lymphocytes stained for B220, two types of IgM and κ or λ. The percentage of each subset is indicated in the appropriate gate.
The data presented are representative of at least four individual mice; (d) statistical analysis of κ:λ ratios based on the data from subﬁgure
b. The ratios of κ to λ on splenic B cells in transgenic and WT mice are indicated by bars; (e) statistical analysis of κ:λ ratios based on the
data from subﬁgure c. The ratios of κ to λ on bovine IgM-expressing B cells and mouse IgM-expressing B cells in transgenic or WT mice
are indicated by bars (***: P< 0.001).
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endogenous IGHC genes were used in one- or two-round
RT-PCR using splenic RNA as a template. The bovine VDJ
exon was observed to be trans-spliced to the endogenous μ,
δ, γ and α genes. Bovine VDJ-Cα transcripts were easily
detected after even one round of PCR. To exclude the
possibility that the trans-spliced transcripts were generated
by class-switch recombination (CSR) between the bovine
Sμ and endogenous switch regions (S regions), we used
primers derived from the 5′ ﬂanking region of the bovine
Sμ and the 3′ ﬂanking sequences of the endogenous S
region to amplify recombined S fragments. This ampliﬁca-
tion proved impossible, leaving trans-splicing as the most
plausible explanation for these data.
3.7 The VH and VL repertoire of endogenous Ig genes in
transgenic mice
To analyze how the repertoire of endogenous mouse Ig
genes was inﬂuenced by the expression of the bovine IgM
transgene, splenically expressed VH, Vκ and Vλ were
ampliﬁed and sequenced in both transgenic and WT mice.
Among 71 VH fragments cloned from WT mice, 63 were
found to contain unique CDR3 sequences (88%, 63/71),
each representing an independent VDJ recombination
event (Table 1). The ratio was reduced to 74% (57/77,
P< 0.05) in Line 22 and 48% (42/87, P< 0.001) in Line
15, indicating that the VDJ recombination of endogenous
mouse IgH was inhibited by the transgene (Table 1). This
observation is consistent with the ﬂow cytometry data. The
VJ recombination of the κ light chain was only slightly
affected, if at all. The observed ratios of 59% (56/94) in
Line 15 and 67% (62/92) in Line 22 were not signiﬁcantly
different from the ratio of 69% (65/94) in WT mice (Table
1). However, the VJ recombination events for the λ light
chain were markedly increased in the transgenic mice
(24%, 19/78 in Line 15, P< 0.001; and 13%, 11/83 in Line
22, P< 0.05) compared to the WT mice, in which only
three unique CDR3 sequences were observed in 86 cloned
Vλ fragments (approximately 3%) (Table 1). Despite these
changes, the CDR3 length and the number of non-
templated (N) and palindromic (P) nucleotides in the V
(D)J junctions of VH, Vκ and Vλ were not markedly
different between transgenic and WT mice (Table 1).
To analyze the repertoire of endogenous Ig genes in the
bovine IgM-expressing B cells (bIgM+) and mouse IgM-
expressing B cells (mIgM+) of the transgenic mice, the
bIgM+ and mIgM+ cells in the spleen from one transgenic
line were sorted by ﬂow cytometry, respectively. Then VH,
Vκ and Vλ were ampliﬁed and sequenced in both
transgenic and WT mice. Among 64 VH fragments cloned
from transgenic mice, 26 were found to contain unique
CDR3 sequences (41%, 26/64, P< 0.001), each represent-
ing an independent VDJ recombination event (Table 2).
For κ light chain, the ratios of 46% (34/74, P< 0.05) in
mIgM+ cells and 59% (63/107) in bIgM+ cells were
observed in the transgenic mice, which is different from the
ratio of 69% (65/94) in WT mice (Table 2). While the VJ
recombination events for the λ light chain were markedly
increased in the bIgM+ cells (28%, 17/61, P< 0.001)
compared to the WTmice(Table 2), we could not ampliﬁed
Vλ from the mIgM+ cells, possibly because λ light chain
rarely expressed in these positive cells. The same as our
previous analysis results, the CDR3 length and the number
of non-templated (N) and palindromic (P) nucleotides in
the V(D)J junctions of VH, Vκ and Vλ were not markedly
different between IgM positive cells(bovine IgM or mouse
IgM) in the transgenic and WT mice.
Frequency analyses of the usage of speciﬁc variable (V),
diversity (D) and joining (J) gene segments in the clones
revealed some consistent differences between transgenic
and WT mice. For instance, the use of the immunoglobulin
heavy chain variable gene family 7 (IGHV7), immunoglo-
bulin heavy chain diversity gene family 2 (IGHD2),
immunoglobulin heavy chain joining gene family 3
(IGHJ3), immunoglobulin κ chain variable gene family 1
(IGKV1) and immunoglobulin λ chain variable gene
family 1 (IGLV1) members was greatly increased in the
transgenic mice, whereas the opposite was found for
IGHV8, IGHV14, IGHD4, IGKV12 and immunoglobulin
λ chain joining gene family 2 (IGLJ2) members [2].
4 Discussion
In this study, transgenic mice expressing bovine IgM at
high levels were produced. To our knowledge, these are the
ﬁrst transgenic mice that have been developed to express
bovine IgM. These mice analyzed results showed that
(1) the DH and JH segments derived from the duplicated
locus on BTA 11 were able to undergo rearrangement,
(2) bovine IgM was able to mediate allelic exclusion in
mice, (3) the expression of bovine IgM led to a reduced
proportion of pro- and pre-B cells but an increased
proportion of immature B cells, (4) bovine IgM-expressing
B cells were able to migrate from the bone marrow to
peripheral lymphoid tissues, but most of them were
blocked at the T1 transitional stage and could not develop
into mature B cells, (5) the animals were deﬁcient in the
speciﬁc IgG antibody response, and (6) the endogenous Ig
repertoire was altered by bovine IgM expression.
IgM is an ancient, structurally conserved Ig class that is
expressed by all jawed vertebrates [1,2]. It is also the ﬁrst
surface Ig expressed on the B cells that can drive further B
cell differentiation. IgM heavy chain constant regions in
different mammals, such as cattle, humans and mice, differ
by as much as 40% in amino-acid sequence although
transmembrane domains are nearly identical. It has
previously been reported that the human IgM gene is
functional in both mice and cattle [13,24]. In this study, we
demonstrated that the bovine IgM gene was able to
mediate allelic exclusion in mice in spite of signiﬁcant
structural and sequence differences. High levels of bovine
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IgM expression largely inhibited the expression of
endogenous mouse IgM, and bovine IgM-expressing B
cells were able to undergo development in the bone
marrow and migrate to peripheral lymphoid tissues. As
SLC encoding genes have also been identiﬁed in cattle
[33], it is therefore highly likely that the bovine IgM heavy
chain can form pre-BCR or BCR complexes with the
mouse SLC or conventional light chain and Igα/Igβ on the
mouse B cells, and this bovine IgM pre-BCR may provide
feedback signals to inhibit VDJ rearrangement at the
endogenous IgH locus. However, as recent studies have
revealed that feedback inhibition by pre-BCR may not be
the only mechanism responsible for IgH allelic exclusion
[12], it is also possible that the bovine IgM heavy chain
alone could mediate allelic exclusion, given that it does not
bind the mouse SLC to form pre-BCR. In this regard, it
would be interesting to investigate whether the mouse
VpreB and l5 are present on the surface of the bovine IgM
expressing B cells at their early developmental stages.
As shown in Fig. 4c, approximately 9.2% of splenic and
5.4% of blood B cells in transgenic mice expressed both
bovine IgM and murine IgM on their surfaces, so it seems
that the expression of bovine IgM does not exert stringent
allelic exclusion. It is unlikely that this arises because of
the bovine sequence of the transgene. Similar phenomena
have been observed in previous studies of Ig transgenic
mice [31,32,34,35]. In these cases, as in the report
presented here, the proportion of B cells that express two
heavy chains far exceeds that observed in WT mice
(approximately 0.01% of double heavy-chain-producing
cells) [36]. This high frequency of allelic inclusion has
several possible explanations: (1) similar to previously
reported studies [31,32], RNA trans-splicing between
transgene and endogenous IGHC genes is responsible for
the production of these double heavy-chain-producing
cells. Indeed, we could detect trans-splicing events
between bovine VDJ exon and endogenous IGHC genes
in the transgenic mice reported in this study; (2) it is also
likely that during the development of these double
producers, the expression of the bovine IgM occurred
after the VDJ rearrangement and expression of the
endogenous mouse IgM; (3) allelic exclusion could be
far more complex than a simple feedback mechanism
initiated by an expressed heavy chain and may involve
many factors, such as enhancers, the chromosomal
positioning of the IgH locus or the amount of IgH
expressed in a given B cell.
In the transgenic mice that expressed bovine IgM at high
levels, most bovine IgM-expressing B cells were blocked
at the T1 transitional stage, though they were able to
migrate to peripheral lymphoid tissues from the bone
marrow. Consequently, mature B cells were largely
reduced in these mice. Similar observations have been
reported for other Ig transgenic mice and rabbits [18,19].
However, Herzenberg et al. failed to perform a detailed
characterization of the B cell populations in their
transgenic mice [18]. Thus, it was difﬁcult to judge at
which stage B cell development was terminated, though a
reduction in the pre-B cell population was noted. In IgH
transgenic rabbits, the presence of the foreign IgH
Table 1 Analysis of CDR3 length and number of N and P nucleotides in transgenic and WT mice
IGH IGK IGL
Unique/Total CDR3 D 5′ N+ P D 3′ N+ P Unique/Total CDR3 N+ P Unique/Total CDR3 N+ P
WT 63/71
(88%)
10.893.03 3.113.26 1.512.33 65/94
(69%)
8.950.51 0.501.64 3/86
(3.5%)
11.002.00 0
T15 42/87
(48%)***
10.452.62 2.002.85 1.482.03 56/94
(59%)
8.910.39 0.180.77 19/78
(24%)***
10.001.67 0.260.73
T22 57/77
(74%)*
11.112.94 2.263.23 2.353.06 62/92
(67%)
9.020.46 0.160.76 11/83
(13%)*
11.441.94 0.751.04
Note: The ratios of unique to total numbers are listed in the table and assessed by Chi-square tests between transgenic and WT groups (*: P< 0.05, ***: P< 0.001). N
nucleotides (N): non-templated nucleotides; P nucleotides (P): palindromic nucleotides.
Table 2 Analysis of CDR3 length and number of N and P nucleotides in IgM positive cells of transgenic and WT mice
IGH IGK IGL
Unique/Total CDR3 5′ N+ P 3′ N+ P Unique/Total CDR3 N+ P Unique/Total CDR3 N+ P
WT 63/71
(88%)
10.893.03 3.113.26 1.512.33 65/94
(69%)
8.950.51 0.501.64 3/86
(3.5%)
11.002.00 0
mIgM 26/64
(48%)***
10.702.36 2.222.61 1.522.57 34/74
(46%)*
7.850.31* 0.090.29***
bIgM 63/107
(59%)
8.540.37* 0.371.56 17/61
(28%)***
10.752.01 0.350.86***
Note: The ratios of unique to total numbers are listed in the table and assessed by Chi-square tests between transgenic and WT groups (*: P< 0.05, ***: P< 0.001).
N nucleotides (N): non-templated nucleotides; P nucleotides (P): palindromic nucleotides.
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transgene prevented the transition from large (early) pre-B
to small (late) pre-B cells [19]. In both examples, the
transgenic animal lines were created with transgenes
derived from the homologous species. In our transgenic
mice, the transgene was of bovine origin. Although the
pro- and pre-B cell populations were reduced by 2- to 3-
fold, the immature B cell (expressing bovine IgM)
population was increased by 2- to 3-fold compared to
that of WT mice. These observations suggest that the
forced expression of bovine IgM facilitated the develop-
ment of B cells to an immature stage in the bone marrow
and that the B cell developmental defect occurred in the
peripheral lymphoid tissues but not in the bone marrow.
It is not yet clear why most of the bovine IgM-
expressing B cells were blocked at the T1 stage. Given that
both T2 and mature B cells express IgD on their surface
while T1 B cells do not [28], it is possible that the
expression of IgD is involved in B cell development in two
different ways. First, it is possible that surface IgD
expression is necessary for B cell development to the T2
and mature stages. The bovine IgM-expressing B cells
should not be able to develop to the T2 and mature stages
because bovine IgM inhibits the expression of the
endogenous IgH genes and therefore inhibits the expres-
sion of mouse IgD. However, this does not appear to be the
case. Most B cells could develop to a mature stage in IgD-
deﬁcient mice, though the total number of B cells was
reduced [37,38]. Furthermore, it is possible that surface
IgD expression is an outcome of B cell development. In
normal mice, each stage of B cell development is
associated with speciﬁc molecular signals, which in turn
drive the next stage of development. Foreign transgenes
may not be able to initiate the proper signals in a given
developmental stage. The presence of a pseudo-δ gene on
the transgene used in our experiments is also of potential
relevance. Thus, the activation of the endogenous IgH
locus as a whole (not only the expression of IgM) may be
required to initiate certain developmental signal(s) that
could not be triggered by the artiﬁcial, transgenic IgH
genes. Alternatively, because each transgenic IgH gene
enforces the expression of only one IgH, the products of
different transgenes may differ in the strength of their
pairing with the SLC or conventional light chains, thus
resulting in variable signal identity or strength. This may
explain why B cells were blocked at different develop-
mental stages in different IgH transgenic animals.
Independent of the above speculations, there is another
possibility that may also partially explain why bovine IgM-
expressing B cells were arrested at the T1 stage. In
mammals, the expression ratios of λ/κ light chains vary
considerably across species. For example, the ratio is
approximately 95/5 in cattle, but it is 40/60 in humans and
5/95 in mice [39]. These widely varying ratios are, apart
from the relative complexity of two light chain germline
repertoires, an outcome of endogenous selection to restrict
self-reactivity in different species [39]. It is also known
that negative selection of self-reactive immature B cells
can occur at the T1 stage in addition to in the bone marrow
[40]. In this regard, there might be a preference for bovine
IgM pairing with λ chains, and most B cells expressing
bovine IgM and mouse κ chains may not be able to pass the
selection at the T1 stage.
Compared with WT mice, it is surprisingly that the
transgenic mice showed slightly increased IgA levels,
although both endogenous IgM and IgG were decreased in
the serum. This ﬁnding is somewhat consistent with a
previous report that IgA production could be detected in
μMT mice, which expressed no IgM and IgG [41],
supporting the presence of an IgM-independent pathway
for IgA production [41]. Possibly, this pathway may be
ascribed to RNA trans-splicing. If so, it would be
interesting to ﬁgure out why only IgA, but not other
non-IgM/IgD isotypes are involved.
A signiﬁcantly reduction of VDJ recombination event
was found in mouse IgM-expressing B cells of the
transgenic mice when compared to that of the WT mice,
indicating that endogenous IgH rearrangement was
inhibited by the transgene. It is also worth noting that the
proportion of λ light chain-containing immunoglobulins
was elevated in the serum of the transgenic mice. This is
consistent with the fact that the λ chain repertoire was
signiﬁcantly increased in the transgenic mice, while the κ
chain repertoire remained comparable to that of the WT
mice. However, the Vκ repertoire of mouse IgM-expres-
sing cells from spleen was reduced in the transgenic mice.
while a signiﬁcantly higher ratio of mouse IgM-expressing
B cells tended to use λ chains when compared to those of
the WT mice. Although it is unclear why this occurred, the
mouse IgM-expressing B cells constituted a majority of the
mature B cell population and thus the plasma cell
population and serum Ig levels as well.
5 Conclusions
Although a number of IgH transgenic mice have been
previously studied, both similar and distinct characteristics
have been reported in these genetic models compared to
our mice. Our experiments show that functional rearrange-
ment of the DH and JH segments present on BTA 11 can
take place, but of wider signiﬁcance, that allelic exclusion
at the IgH locus can be driven by expression of a
heterologous IgM construct. A thorough analysis of B cell
development in these mice is still needed to gain further
insight into underlying regulatory mechanisms.
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